Vice Provost and Dean of Research
Showing 461-480 of 570 Results
-
David Solow-Cordero
Associate Director, High-Throughput Screening, Innovative Medicines Accelerator (IMA)
Current Role at StanfordAssociate Director, High-Throughput Screening Knowledge Center, , Sarafan ChEM-H and Innovative Medicine Accelerator (IMA)
This high-throughput screening (HTS) laboratory allows Stanford researchers and others to discover novel modulators of targets that otherwise would not be practical in industry. The center incorporates instrumentation (purchased with NCRR NIH Instrumentation grant numbers S10RR019513, S10RR026338, S10OD025004, and S10OD026899), databases, compound libraries, and personnel whose previous sole domains were in industry.
Among our instrumentation are a fully automated Molecular Devices ImageXpress Micro Confocal High-Content fluorescence microplate imager, with live cell, fluidics and phase contrast options, an Echo 655 Acoustic Dispense, a Thermo integrated HTS robotic system, a Caliper Life Sciences SciClone ALH3000 and an Agilent Bravo microplate liquid handler, and the BMG Clariostarplus, Tecan Infinite M1000 and M1000 PRO and Molecular Devices FlexStation II 384 fluorescence, luminescence and absorbance multimode microplate readers.
We have over 180,000 small molecules for compound screens, 15,000 cDNAs for genomic screens, and whole genome siRNA libraries targeting the human genome (the siARRAY whole human genome siRNA library from Dharmacon, targeting 21,000 human genes) and the mouse genome (Qiagen mouse whole genome siRNA set V1 against 22,124 genes).
The HTSKC main screening lab is located in ChEM-H W008, the cell-based assay development lab is located in CCSR Room 0133-North Wing, between the Transgenic Mouse Facility, and the Stanford Genomics Facility. -
Tatiana Sorokina
Senior Associate Director, Industrial Contracts Office, Office of Technology Licensing (OTL)
Current Role at StanfordSenior Contracts Officer, Industrial Contracts Office
-
Michael Spaid
Licensing Manager, Physical Sciences, Office of Technology Licensing (OTL)
BioMichael joined Stanford's Office of Technology Licensing (OTL) in 2024 as a Licensing Manager, Physical Sciences. He brings over 20 years of experience leading multidisciplinary teams from concept to commercialization in start-ups across biotechnology, nanotechnology, and medical devices.
Education:
BS in Chemical Engineering, Tulane University
MS and PhD in Chemical Engineering, Stanford University -
Drew Spence
Policy Program Manager, Institute for Human-Centered Artificial Intelligence (HAI)
BioDrew Spence serves as Policy Program Manager for the Stanford Institute for Human-Centered Artificial Intelligence (HAI) where he leads policy education programs, student fellowships, and outreach to policymakers in Washington and beyond. Prior to joining the team at HAI, Drew held multiple roles in government, most recently on former Vice President Kamala Harris' legislative affairs team. He also served in the U.S. Department of the Treasury, in the U.S. Senate, and in the California Attorney General's office. He is a graduate of George Washington University.
-
Richard Stern
Part-Time Patent Agent (Life Sciences), Office of Technology Licensing (OTL)
Staff, Stanford Office of Technology LicensingBioRichard is a patent agent with Stanford's Office of Technology Licensing (OTL). He holds a PhD in molecular genetics and microbiology from the University of Florida, Gainesville. Before joining the OTL, he spent over two decades working as a patent agent in both full-service and boutique law firms, and in industry. At the OTL, Richard evaluates life science discoveries and helps develop IP strategy.
Richard is registered with the United States Patent and Trademark Office (USPTO).
